CTOs on the Move

Mid-Atlantic Imaging Services

www.maiedge.com

 
Mid-Atlantic Imaging Services is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.maiedge.com
  • 9051 Red Branch Rd Ste C
    Columbia, MD USA 21045
  • Phone: 888.247.8840

Executives

Name Title Contact Details

Similar Companies

Carter Dental Lab

Carter Dental Lab is a Stuttgart, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ez Way

Ez Way is a Clarinda, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avalign Technologies

Avalign Technologies is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Orthodontic Supply of Canada

Orthodontic Supply of Canada is a Lincoln, NB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Transgenomic

Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.  Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.